Перевести на Переведено сервисом «Яндекс.Перевод»

Sunesis Pharmaceuticals

Country
USA
Краткое название
Sunesis Pharmaceuticals
Headquarters
395 Oyster Point Boulevard Suite 400
Members of the board

Daniel N. Swisher, Jr.,
Chief Executive Officer and President
Eric H. Bjerkholt,
Executive Vice President, Corporate Development and Finance, Chief Financial Officer
Adam R. Craig, M.D., Ph.D., M.B.A,
Executive Vice President, Development and Chief Medical Officer
Gene Jamieson,
Vice President of Chemistry, Manufacturing and Controls (CMC)
Deborah A. Thomas, Ph.D.,
Vice President, Regulatory Affairs and Medical Writing

Categories medicine
Oncology
Stage of the project
Production
Disease
Blood cancer, Intestine cancer, Gastric cancer
Ticker
SNSS
Current owners

Matthew K. Fust,
Director
Ed Hurwitz,
Director
Steven B. Ketchum, Ph.D.,
Director
Helen Kim,
Director
Dayton Misfeldt,
Director
Homer L. Pearce, Ph.D.,
Director
David C. Stump, M.D.,
Director
Daniel N. Swisher, Jr.,
Chief Executive Officer and President
James W. Young, Ph.D.,
Chairman

Assets
208.6700
Technology
Cell Technologies, Pharmaceuticals, Chemistry